Pathology In Cancer Research Task Force
The AACR Pathology in Cancer Research Task Force has been formed to assist the AACR in optimizing opportunities for pathologists and pathology-focused research. It is charged with helping the AACR understand the needs of current pathologists, increasing the visibility of pathology-focused research both within the AACR and externally, ensuring that pathology researchers are integrated into AACR activities, and identifying barriers specific to the development of the next generation of pathologists.
Chair
Members
Olusegun Isaac Alatise, MBChB,MD,MS, Obafemi Awolowo University, Ile-Ife, Nigeria
Michael R. Angelo, MD, PhD, Stanford University, Palo Alto, California
Sunil S. Badve, MBBS, MD, Emory University School of Medicine, Atlanta, Georgia
Andrew H. Beck, MD, PhD, PathAI, Inc., Cambridge, Massachusetts
Alexander S. Brodsky, PhD, Rhode Island Hosp./Brown Univ. Med. School, Providence, Rhode Islans
Carolyn C. Compton, MD, PhD, Arizona State University, Scottsdale, Arizona
Suzana S. Couto, DVM, PhD, Genmab, Princeton, New Jersey
Angelo M. DeMarzo, MD, PhD, Johns Hopkins University School of Medicine, Baltimore, Maryland
Jayanta Debnath, MD, UCSF – University of California San Francisco, San Francisco, California
Kojo Elenitoba-Johnson, MD, Perelman School of Med. Univ. of Pennsylvania, Philadelphia, Pennsylvania
Michelangelo Fiorentino, MD, University of Bologna, Bologna, Italy
Chris A. French, MD, Harvard Medical School, Boston, Massachusetts
Thomas J. Fuchs, PhD, Icahn School of Medicine at Mount Sinai, New York, New York
Kevin L. Gardner, MD, PhD, Vagelos College of Physicians & Surgeons, New York, New York
Felice Giangaspero, MD, Università Sapienza di Roma UOC Anatomia Patologica e Citodiagnostica, Rome, Italy
Jennifer M. Giltnane, MD, PhD, Genentech, Inc., South San Francisco, California
Jiaoti Huang, MD, PhD, Duke University School of Medicine, Durham, North Carolina
A.John Iafrate, MD, PhD, Massachusetts General Hospital, Boston, Massachusetts
Michael M. Ittmann, MD, PhD, Baylor College of Medicine, Houston, Texas
Roy A. Jensen, MD, University of Kansas Cancer Center, Kansas City, Kansas
Jakob N. Kather, MD, Technical University Dresden, Dresden, Germany
Annette S. Kim, MD, PhD, Brigham and Women’s Hospital, Boston, Massachusetts
Michael Kluk, MD, PhD, Weill Cornell Medicine, New York, New York
Robin G. Lorenz, MD, PhD, Genentech, Inc., South San Francisco, California
Tamara L. Lotan, MD, Johns Hopkins University School of Medicine, Baltimore, Maryland
Anirban Maitra, MBBS, UT MD Anderson Cancer Center, Houston, Texas
Diana Mandelker, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, New York
Caterina Marchio, MD, PhD, University of Turin, Candiolo, Italy
Gerrit A. Meijer, MD, PhD, Netherlands Cancer Institute, Amsterdam, Netherlands
Richard N. Mitchell, MD, PhD, Harvard Medical School, Boston, Massachusetts
Anil V. Parwani, MD, PhD, The Ohio State University Wexner Medical Ctr., Columbus, Ohio
Francesco Pezzella, MD, University of Oxford, Oxford, United Kingdom
Eli Pikarsky, MD (hc), PhD, The Hebrew University of Jerusalem, Jerusalem, Israel
Nicholas P. Reder, MD, Univ. of Washington Medical Ctr., Seattle, Washington
Jorge S. Reis-Filho, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, New York
Andrea L. Richardson, MD, PhD, Johns Hopkins University School of Medicine, Washington, DC
David L. Rimm, MD, PhD, Yale School of Medicine, New Haven, Connecticut
Mark A. Rubin, MD, University of Bern, Bern, Switzerland
Kalliopi P. Siziopikou, MD, PhD, Northwestern Univ. Feinberg School of Medicine, Chicago, Illinois
Lawrence D. True, MD, University of Washington, Seattle, Washington
Jose G. van den Berg, MD, PhD, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands
Anne Vincent-Salomon, MD, PhD, Institut Curie, Paris, France
Britta Weigelt, PhD, Memorial Sloan Kettering Cancer Center, New York, New York
Ignacio I. Wistuba, MD, UT MD Anderson Cancer Center, Houston, Texas
Laura D. Wood, MD, PhD, Johns Hopkins University School of Medicine, Baltimore, Maryland
Contact Information
Lyngine Calizo, PhD
Phone: 215-446-7265
Fax: 267-825-9545
Email: [email protected]